A share price of Veracyte Inc [VCYT] is currently trading at $41.7, up 0.02%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The VCYT shares have gain 15.58% over the last week, with a monthly amount glided 19.38%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Veracyte Inc [NASDAQ: VCYT] stock has seen the most recent analyst activity on October 20, 2025, when Canaccord Genuity initiated its Hold rating and assigned the stock a price target of $40. Previously, Craig Hallum started tracking the stock with Buy rating on March 20, 2025, and set its price target to $45. On December 05, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $37 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $50 on November 15, 2024. UBS initiated its recommendation with a Buy and recommended $43 as its price target on October 16, 2024. Guggenheim started tracking with a Buy rating for this stock on October 10, 2024, and assigned it a price target of $40. In a note dated February 23, 2024, Needham reiterated an Buy rating on this stock and boosted its target price from $30 to $33.
Veracyte Inc experienced fluctuations in its stock price throughout the past year between $22.61 and $47.32. Currently, Wall Street analysts expect the stock to reach $39.67 within the next 12 months. Veracyte Inc [NASDAQ: VCYT] shares were valued at $41.7 at the most recent close of the market. An investor can expect a potential drop of -4.87% based on the average VCYT price forecast.
Analyzing the VCYT fundamentals
Trailing Twelve Months sales for Veracyte Inc [NASDAQ:VCYT] were 495.14M which represents 13.82% growth. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.05%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 40.47 points at the first support level, and at 39.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 42.42, and for the 2nd resistance point, it is at 43.13.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Veracyte Inc [NASDAQ:VCYT] is 6.23. As well, the Quick Ratio is 5.94, while the Cash Ratio is 4.37. Considering the valuation of this stock, the price to sales ratio is 6.66, the price to book ratio is 2.62 and price to earnings (TTM) ratio is 109.82.
Transactions by insiders
Recent insider trading involved McGuire Annie, SVP, General Counsel, that happened on Nov 05 ’25 when 6466.0 shares were sold. Director, JONES EVAN/ FA completed a deal on Nov 05 ’25 to sell 43196.0 shares. Meanwhile, Director EASTHAM KARIN sold 9674.0 shares on Nov 05 ’25.
